Unichem Laboratories Ratios

Unichem Laboratories Ltd Ratios

The Unichem Laboratories Ltd Ratios page provides a complete fundamental analysis of Unichem Laboratories Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Unichem Laboratories Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Unichem Laboratories Ltd (NSE: UNICHEMLAB, BSE: 506690) is currently trading at ₹346.20, with a market capitalization of ₹24.44B. As a major player in the Health technology sector and Pharmaceuticals: major industry, Unichem Laboratories Ltd remains a key stock for fundamental analysis using Unichem Laboratories Ltd Ratios.

Unichem Laboratories Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Unichem Laboratories Ltd P/E ratio currently stands at 35.58, making it one of the most tracked metrics in Unichem Laboratories Ltd Ratios.

Historically, the Unichem Laboratories Ltd P/E ratio has shown strong fluctuations:

• 2024: 35.58
• 2023: 0
• 2022: 0
• 2021: 55.58
• 2020: 63.44

The rising Unichem Laboratories Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Unichem Laboratories Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.99.

Historical P/B trend:

• 2024: 1.99
• 2023: 1.41
• 2022: 0.84
• 2021: 0.70

Unichem Laboratories Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Unichem Laboratories Ltd P/S ratio currently stands at 2.35, an important part of Unichem Laboratories Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 2.35
• 2023: 1.97
• 2022: 1.54
• 2021: 1.46

The rising Unichem Laboratories Ltd P/S ratio indicates improved revenue valuation by investors.

Unichem Laboratories Ltd Price to Cash Flow Ratio (P/CF)

The Unichem Laboratories Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Unichem Laboratories Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 37.41

The declining Unichem Laboratories Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Unichem Laboratories Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Unichem Laboratories Ltd EV currently stands at ₹52.35B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 52.35B
• 2023: 35.27B
• 2022: 21.62B
• 2021: 18.09B

Unichem Laboratories Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Unichem Laboratories Ltd EV/EBITDA ratio is currently 22.33, a key metric in Unichem Laboratories Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 22.33
• 2023: 0
• 2022: 0
• 2021: 27.08

Higher Unichem Laboratories Ltd EV/EBITDA suggests premium valuation.

Unichem Laboratories Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Unichem Laboratories Ltd D/E ratio is currently 0.19, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.19
• 2023: 0.10
• 2022: 0.13
• 2021: 0.13

Unichem Laboratories Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Unichem Laboratories Ltd ROE currently stands at 5.71%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 5.71
• 2023: -3.85
• 2022: -8
• 2021: 1.28

Declining ROE indicates pressure on profitability.

Unichem Laboratories Ltd Ratios Analysis Summary

The Unichem Laboratories Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Unichem Laboratories Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Unichem Laboratories Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.